How Roche is Transforming Regulatory Compliance with AI and Veeva Vault

Pharmaceutical giant Roche is advancing its enterprise digital strategy by integrating artificial intelligence and modern cloud systems to streamline complex regulatory compliance procedures. Operating globally across Pharmaceuticals and Diagnostics divisions, the organization faces stringent oversight that requires rigorous documentation and multi-jurisdictional approvals. Group CEO Thomas Schinecker notes that the enterprise maintains a comprehensive artificial intelligence strategy centered on everyday productivity and core process restructuring across service, marketing, and research and development.

Transitioning from Documents to Structured Data

Joanne Byrne, Head of Global Regulatory Operations, highlights that the pharmaceutical sector traditionally relies on document-centric workflows that can significantly lengthen approval timelines. When managing submissions globally, teams often experience delays due to sequential review cycles across different regulatory agencies. To address these bottlenecks, Roche is transitioning toward a data-driven model aligned with emerging standards such as M16, M4Q, and IDMP. This shift focuses on standardizing content and data structures to accelerate assembly and facilitate agency tracking.

• Adopting standardized data frameworks to simplify dossier preparation
• Improving visibility and tracking capabilities for regulatory reviewers
• Targeting faster market delivery to bring critical medicines to patients

Core Foundations and the Veeva Platform

Achieving this operational evolution requires robust underlying architecture before advanced automation can succeed. Roche recently concluded a multi-year deployment of the Veeva Vault platform, a cloud-based, multi-tenant environment designed specifically for the life sciences sector. This unified solution consolidates documents, data, and processes across clinical, regulatory, quality, safety, and commercial domains.

By unifying its digital landscape, Roche ensures that cross-functional teams operate within a single enterprise system. This foundational stability allows the organization to explore automated solutions, beginning with health authority inquiries currently managed through the Veeva Vault Regulatory Information Management system. Streamlining these manual questions forms the preliminary step toward broader system optimization.

Deploying Agentic AI and Measuring Success

With core data structures established, Roche is actively experimenting with agentic artificial intelligence to enhance internal workflows. Initial deployment priorities focus heavily on elevating user experience, minimizing mandatory input clicks, and establishing data consistency. To achieve higher data quality, leadership aims to eliminate open text fields where manual entry inconsistencies commonly arise.

• Optimizing core user workflows to reduce administrative friction
• Eliminating free text fields to enhance data entry consistency
• Leveraging insights for advanced regulatory strategies and risk profiling

Looking ahead, Roche intends to scale its use of data analytics to generate predictive insights concerning regulatory strategy and corporate risk profiles. While recognizing that the industry is navigating a revolutionary and experimental phase, leadership emphasizes that maintaining robust core competencies remains the vital prerequisite for maximizing the value of enterprise artificial intelligence.